Related Experiment Video
Updated: Nov 2, 2025
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
DNA Repair Mechanisms and Therapeutic Targets in Glioma
Kevin B Elmore1, Lauren R Schaff2
1Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Purpose Of Review:
This review discusses current and investigative strategies for targeting DNA repair in the management of glioma.
Recent Findings:
Recent strategies in glioma treatment rely on the production of overwhelming DNA damage and inhibition of repair mechanisms, resulting in lethal cytotoxicity. Many strategies are effective in preclinical glioma models while clinical feasibility remains under investigation. The presence of glioma biomarkers, including IDH mutation and/or MGMT promoter methylation, may confer particular susceptibility to DNA damage and inhibition of repair. These biomarkers have been adopted as eligibility criteria in the design of multiple ongoing clinical trials. Targeting DNA repair mechanisms with novel agents or therapeutic combinations is a promising approach to the treatment of glioma. Further investigations are underway to optimize this approach in the clinical setting.
Insights
Targeting DNA repair is a promising strategy for glioma treatment, especially when combined with biomarkers like IDH mutation or MGMT promoter methylation. Further research is needed to optimize these DNA-damaging approaches for clinical use.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Glioma treatment faces challenges with current therapeutic options.
- DNA repair mechanisms play a crucial role in cancer cell survival.
- Overwhelming DNA damage is a key strategy in novel glioma treatments.
Purpose of the Study:
- To review current and investigative strategies for targeting DNA repair in glioma management.
- To highlight the role of biomarkers in predicting treatment response.
- To assess the clinical feasibility of DNA repair inhibition in glioma.
Main Methods:
- Review of preclinical and clinical studies on DNA repair inhibition in glioma.
- Analysis of the impact of glioma biomarkers (IDH mutation, MGMT promoter methylation) on treatment efficacy.
- Examination of ongoing clinical trials investigating DNA repair targeting agents.
Main Results:
- Strategies inducing overwhelming DNA damage and inhibiting repair show promise in preclinical glioma models.
- Biomarkers such as IDH mutation and MGMT promoter methylation may enhance susceptibility to DNA repair inhibition.
- Clinical feasibility of these strategies is still under investigation.
Conclusions:
- Targeting DNA repair mechanisms represents a promising therapeutic avenue for glioma.
- Biomarker-guided approaches are being integrated into clinical trial designs.
- Further research is essential to optimize the clinical application of DNA repair inhibition in glioma treatment.
More Related Videos
08:21Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
Published on: September 1, 2019
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
Related Concept Videos
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:02Long-patch Base Excision Repair
02:25Overview of DNA Repair
Chemically...
02:25Overview of DNA Repair